While early studies focused heavily on the involvement of PPAR-γ in the process of colonic tumor suppression, more recently, research has expanded to include intestinal inflammation and fibrosis, major factors in the pathogenesis of IBD. Here, PPARG is linked to inflammatory bowel disease.